ArticleCancers2022

Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration.

Ju-Pi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.